FDA warns Canadian company for selling unapproved, misbranded drugs

As bipartisan support in Congress for importation grows, FDA warns that a Canadian company is selling unapproved and misbranded drugs to U.S. consumers.

FDA accused CanaRx

Read the full 255 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE